DNM1L and Huntington disease: In addition, tissues from Alzheimer’s disease (AD) [124] and Huntington's disease (HD) [125] patients demonstrated increased expression of DRP1 and FIS1, and decreased expression of MFN1, MFN2 and OPA1, indicating that an impairment on mitochondrial dynamics are associated with AD and HD.